Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer DB Geography — United States Revenues by Quarter
DB Geography — United States Revenues ($M) ($M)
Pfizer DB Geography — United States Revenues: $8,857M in Q2 2026, down 0.4% from a year earlier.
Latest, Q2 2026
8,857
Period ended Jun 28, 2026
Change on a year earlier
-0.4%
8,894 in Q2 2025
History
62 quarters
Since Q1 2011
Sources
45
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Geography — United States Revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 8,857 | -0.4% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 8,731 | +4.3% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 9,119 | -1.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 10,691 | -11.4% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 8,894 | +12.7% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 8,374 | -12.0% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 9,221 | +87.7% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 29, 2024 | 12,064 | +49.6% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 7,892 | +22.2% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 9,514 | +9.2% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 4,912 | -47.3% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 8,064 | -41.8% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 6,458 | -42.5% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 8,711 | -2.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 9,326 | +21.4% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | 13,851 | +97.3% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 11,222 | +49.3% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 8,918 | +18.4% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 7,680 | +36.5% | Form 10-Q (filed 2022-11-09) ↗ |
| Q3 2021 | Oct 3, 2021 | 7,020 | +29.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | 7,515 | +47.0% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | 7,530 | +42.4% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,628 | +186.3% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2020 | Sep 27, 2020 | 5,425 | -7.3% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 5,113 | -19.3% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 5,289 | -14.3% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,966 | +56.3% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | 5,850 | -8.0% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 6,335 | +1.8% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 6,175 | -1.6% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,258 | -80.7% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | 6,361 | -2.6% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 6,225 | -1.9% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 6,275 | -5.5% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 6,510 | -4.4% | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2017 | Oct 1, 2017 | 6,534 | +0.1% | SEC Filing ↗ |
| Q2 2017 | Jul 2, 2017 | 6,345 | -0.4% | SEC Filing ↗ |
| Q1 2017 | Apr 2, 2017 | 6,637 | -0.4% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 6,808 | +1.4% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Oct 2, 2016 | 6,530 | +17.3% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 6,370 | +27.6% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 6,661 | +50.3% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 6,711 | +32.9% | Form 10-K (filed 2016-02-29) ↗ |
| Q3 2015 | Sep 27, 2015 | 5,565 | +14.9% | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 4,994 | +1.8% | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 4,433 | +3.7% | SEC Filing ↗ |
| Q4 2014 | Dec 31, 2014 | 5,050 | -0.7% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 28, 2014 | 4,842 | -6.6% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 29, 2014 | 4,906 | -3.6% | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 30, 2014 | 4,275 | -13.0% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 5,084 | -4.1% | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2013 | Sep 29, 2013 | 5,186 | +0.2% | Form 10-Q (filed 2013-11-08) ↗ |
| Q2 2013 | Jun 30, 2013 | 5,090 | -4.1% | Form 10-Q (filed 2013-08-09) ↗ |
| Q1 2013 | Mar 31, 2013 | 4,914 | -17.4% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 5,302 | +13.4% | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 5,174 | -24.8% | Form 10-Q (filed 2013-11-08) ↗ |
| Q2 2012 | Jul 1, 2012 | 5,307 | -20.8% | Form 10-Q (filed 2013-08-09) ↗ |
| Q1 2012 | Apr 1, 2012 | 5,952 | -15.3% | Form 10-Q (filed 2013-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 4,674 | – | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2011 | Oct 2, 2011 | 6,879 | – | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2011 | Jul 3, 2011 | 6,700 | – | Form 10-Q (filed 2012-08-09) ↗ |
| Q1 2011 | Apr 3, 2011 | 7,024 | – | Form 10-Q (filed 2012-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer DB Geography — United States Revenues ($M), quarterly Q1 2011–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-geo-rev-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.